Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast
Clinical trial NCT02517372 · COMPLETED
Trial details
- NCT number
- NCT02517372
- Sponsor
- RSPR Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.